Detalhe da pesquisa
1.
Effect of KRAS exon 2 mutations on antitumor activity of afatinib and gefitinib.
Anticancer Drugs
; 26(4): 371-8, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25514114
2.
KRAS exon 2 mutations influence activity of regorafenib in an SW48-based disease model of colorectal cancer.
Future Oncol
; 11(13): 1919-29, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26161928
3.
Radiographically occult perforation and dissection of the common carotid artery following stab injury to the neck.
Trauma Case Rep
; 9: 17-21, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29644318